• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子α信号在实验性小鼠肝前门静脉高压症发展中的作用

Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension.

作者信息

Theodorakis Nicholas G, Wang Yining N, Wu Jianmin, Maluccio Mary A, Skill Nicholas J

机构信息

Indiana University, Department of Surgery Indianapolis, IN, 46202, USA.

出版信息

Int J Physiol Pathophysiol Pharmacol. 2010 Mar 8;2(2):104-110.

PMID:21383890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3047261/
Abstract

The cytokine tumor necrosis factor alpha (TNFa) has previously been identified in the development of portal hypertension (PHT) by facilitating portal venous and systemic hyperemia. TNFa is reported to contribute to hyperemia via endothelial nitric oxide synthase (eNOS) induction and nitric oxide (NO) production. This study examines this hypothesis by utilizing TNFa receptor knockout mice and a murine model of pre-hepatic PHT. Plasma TNFa and NOx and tissue TNFa mRNA levels were determined in wild-type mice 0-7d post induction of pre-hepatic PHT by partial portal vein ligation (PVL). TNFa receptor knockout mice also received PVL or sham surgery and splenic pulp pressure, abdominal aortic flow and portal-systemic shunting were recorded 7d following. Portal pressure and systemic hyperemia developed rapidly following PVL. Plasma NOx was increased temporarily 2-3 days following PVL and returned to baseline by day 7. Circulating TNFa was below detectable limits of the ELISA used, as such no increase was observed. Hepatic and vascular TNFa mRNA levels were transiently changed after PVL otherwise there was no significant change. TNFa receptor targeted gene deletion did not ameliorate plasma NOx following PVL and had no effect on the development of PHT. TNFa receptor signaling plays no detectable role in the development of systemic hyperemia in the murine model of pre-hepatic PHT. Consequently, increased TNFa observed in intra-hepatic inflammatory models (CCl(4)) and in patients is probably related to inflammation associated with intra-hepatic pathology. Alternatively, TNFa may be signaling via a TNFa receptor independent mechanism.

摘要

细胞因子肿瘤坏死因子α(TNFα)先前已被确定通过促进门静脉和全身充血参与门静脉高压症(PHT)的发展。据报道,TNFα通过诱导内皮型一氧化氮合酶(eNOS)和产生一氧化氮(NO)来促进充血。本研究通过使用TNFα受体敲除小鼠和肝前性PHT的小鼠模型来检验这一假设。在通过部分门静脉结扎(PVL)诱导肝前性PHT后0-7天,测定野生型小鼠的血浆TNFα、NOx和组织TNFα mRNA水平。TNFα受体敲除小鼠也接受PVL或假手术,并在7天后记录脾髓压、腹主动脉血流和门体分流情况。PVL后门静脉压力和全身充血迅速发展。PVL后2-3天血浆NOx暂时升高,到第7天恢复到基线水平。循环中的TNFα低于所用ELISA的检测限,因此未观察到升高。PVL后肝脏和血管TNFα mRNA水平短暂变化,否则无显著变化。TNFα受体靶向基因缺失并未改善PVL后的血浆NOx,对PHT的发展也无影响。在肝前性PHT小鼠模型中,TNFα受体信号传导在全身充血的发展中未发挥可检测到的作用。因此,在肝内炎症模型(CCl₄)和患者中观察到的TNFα增加可能与肝内病理相关的炎症有关。或者说,TNFα可能通过一种不依赖TNFα受体的机制进行信号传导。

相似文献

1
Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension.肿瘤坏死因子α信号在实验性小鼠肝前门静脉高压症发展中的作用
Int J Physiol Pathophysiol Pharmacol. 2010 Mar 8;2(2):104-110.
2
Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.沙利度胺通过不依赖一氧化氮合酶降低收缩压来改善门静脉高压。
World J Gastroenterol. 2015 Apr 14;21(14):4126-35. doi: 10.3748/wjg.v21.i14.4126.
3
Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.内皮型一氧化氮合酶在四氯化碳诱导的肝纤维化模型中门静脉高压发展中的作用。
Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G792-9. doi: 10.1152/ajpgi.00229.2009. Epub 2009 Jul 23.
4
Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.肿瘤坏死因子、内皮素及一氧化氮对急慢性门静脉高压大鼠高动力循环的影响
World J Gastroenterol. 2004 Mar 1;10(5):689-93. doi: 10.3748/wjg.v10.i5.689.
5
The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice.
Gastroenterology. 2003 May;124(5):1500-8. doi: 10.1016/s0016-5085(03)00280-4.
6
Murine study of portal hypertension associated endothelin-1 hypo-response.门静脉高压相关内皮素-1低反应的小鼠研究
World J Gastroenterol. 2015 Apr 28;21(16):4817-28. doi: 10.3748/wjg.v21.i16.4817.
7
Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.肝硬化与大鼠肝前性门静脉高压症中血管一氧化氮生成及全身血流动力学的比较
Hepatology. 1996 Oct;24(4):947-51. doi: 10.1002/hep.510240432.
8
NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.NADPH 氧化酶 1/4 抑制通过调节大鼠肠系膜血管生成和动脉低反应性来减轻门脉高压综合征。
Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):255-265. doi: 10.1016/j.clinre.2018.10.004. Epub 2018 Nov 7.
9
Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.沙利度胺可抑制肿瘤坏死因子α,减少一氧化氮合成,并改善门静脉高压大鼠的高动力循环综合征。
Hepatology. 1996 Jun;23(6):1616-21. doi: 10.1002/hep.510230644.
10
ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats.肝肺综合征中内皮素-1和肿瘤坏死因子-α:大鼠肝前门静脉高压及胆汁性和非胆汁性肝硬化的分析
Am J Physiol Gastrointest Liver Physiol. 2004 Feb;286(2):G294-303. doi: 10.1152/ajpgi.00298.2003.

引用本文的文献

1
Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.沙利度胺通过不依赖一氧化氮合酶降低收缩压来改善门静脉高压。
World J Gastroenterol. 2015 Apr 14;21(14):4126-35. doi: 10.3748/wjg.v21.i14.4126.

本文引用的文献

1
Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.内皮型一氧化氮合酶在四氯化碳诱导的肝纤维化模型中门静脉高压发展中的作用。
Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G792-9. doi: 10.1152/ajpgi.00229.2009. Epub 2009 Jul 23.
2
Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertension.环氧化酶同工型在前列环素生物合成及小鼠肝前门静脉高压中的作用
Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G953-64. doi: 10.1152/ajpgi.00013.2008. Epub 2008 Sep 4.
3
Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1.肿瘤坏死因子-α通过翻译延伸因子1-α 1下调内皮型一氧化氮合酶mRNA的稳定性。
Circ Res. 2008 Sep 12;103(6):591-7. doi: 10.1161/CIRCRESAHA.108.173963. Epub 2008 Aug 7.
4
Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.抗人细小病毒B19 VP1独特区蛋白抗体对血管内皮细胞黏附分子表达的上调及肿瘤坏死因子-α的诱导作用
Clin Chim Acta. 2008 Sep;395(1-2):77-83. doi: 10.1016/j.cca.2008.05.012. Epub 2008 May 19.
5
Portal hypertension and its complications.门静脉高压及其并发症。
Gastroenterology. 2008 May;134(6):1715-28. doi: 10.1053/j.gastro.2008.03.007.
6
Primary prophylaxis of esophageal variceal bleeding in cirrhosis.
Gastroenterol Clin Biol. 2008 May;32(5 Pt 1):532-40. doi: 10.1016/j.gcb.2008.03.012. Epub 2008 May 5.
7
Mechanisms of extrahepatic vasodilation in portal hypertension.门静脉高压症时肝外血管舒张的机制。
Gut. 2008 Sep;57(9):1300-14. doi: 10.1136/gut.2007.144584. Epub 2008 Apr 29.
8
Portal hypertension and variceal hemorrhage.门静脉高压症和静脉曲张出血。
Med Clin North Am. 2008 May;92(3):551-74, viii. doi: 10.1016/j.mcna.2007.12.003.
9
Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress.脂肪组织特异性PPARγ缺乏增加对氧化应激的抗性。
Exp Gerontol. 2008 Mar;43(3):154-63. doi: 10.1016/j.exger.2007.11.002. Epub 2007 Nov 21.
10
PPAR-gamma regulates osteoclastogenesis in mice.过氧化物酶体增殖物激活受体γ调节小鼠破骨细胞生成。
Nat Med. 2007 Dec;13(12):1496-503. doi: 10.1038/nm1672. Epub 2007 Dec 2.